Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. - Abstract - Europe PMC

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

Human Poly (ADP-ribose) Polymerase Family Member 14 (PARP14)

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

1,2,4]Triazolo[3,4-b]benzothiazole scaffold as versatile nicotinamide mimic allowing nanomolar inhibition of different PARP enzymes

Chemical genetic methodologies for identifying protein substrates of PARPs: Trends in Biochemical Sciences

Identification of Protein Substrates of Specific PARP Enzymes Using Analog-Sensitive PARP Mutants and a Clickable NAD+ Analog. - Abstract - Europe PMC

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

NAD-dependent ADP-ribosylation of the human antimicrobial and immune-modulatory peptide LL-37 by ADP-ribosyltransferase-1 - Monica Picchianti, Carla Russo, Marta Castagnini, Massimiliano Biagini, Elisabetta Soldaini, Enrico Balducci, 2015

Chemical ADP-ribosylation: mono-ADPr-peptides and oligo-ADP-ribose - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/C9OB00501C

Intracellular mono-ADP-ribosyltransferases at the host–virus interphase

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules

Inhibitors of PARP: Number crunching and structure gazing